Search results for "Warnings and alerts"
Warnings on fluoroquinolones, antipsychotics, becaplermin
Recalls, warnings, and approvals. ... The drug is already approved to treat depression, anxiety, and diabetic peripheral neuropathic pain.
September 2008
Multistate B. cepacia outbreak linked to foam cleanser
This column reviews details on recent recalls, warnings, and approvals. ... Patients were already hospitalized for acute conditions and acquired the infections during hospitalization.
July 2018
Warnings on insomnia meds, pacemaker battery depletion
This column reviews details on recent recalls, warnings, and approvals. ... before requiring battery replacement, depending on the device and the amount of pacing.
July 2019
New cardiac warning for fluoroquinolones
This column reviews details on recent recalls, warnings, and approvals. ... Common side effects were headache and upper respiratory infection. A boxed warning alerts clinicians about the risk of life-threatening meningococcal infections and sepsis.
February 2019
Boxed warning removed from asthma drugs
This column reviews details on recent recalls, warnings, and approvals. ... Most of the reactions occurred within the first few minutes of infusion, and some required hospitalization.
March 2018
FDA warns about clarithromycin in heart disease
This column reviews details on recent recalls, warnings, and approvals. ... treat systemic and primary cutaneous anaplastic large-cell lymphoma after other treatment failure.
May 2018
First AI device approved to detect diabetic retinopathy
This column reviews details on recent recalls, warnings, and approvals. ... configuration issues disable alarms and alerts.
June 2018
First blood test approved to evaluate concussion
This column reviews details on recent recalls, warnings, and approvals. ... Marketing of clinical decision support software that analyzes patients' computed tomography (CT) results and alerts clinicians of a potential stroke.
April 2018
Peanut butter recall issued, reminder for topical anesthetics
A summary of approvals, recalls, warnings and alerts. ... Side effects may include headache, dizziness, fatigue, drowsiness, gait disturbance, double-vision, nausea and vomiting.
March 2009
Warnings issued for antiepileptics, bowel prep, efalizumab
A summary of approvals, recalls, warnings and alerts. ... and lead to electrolyte imbalance, cardiac dysfunction, gastrointestinal disturbances, paresthesia and mental confusion.
February 2009